Twintic
200 mg + 600 mg
Erythromycin Ethylsuccinate + Sulfisoxazole Acetyl
Segment 05 · Macrolides
Twintic200 mg + 600 mg
Erythromycin Ethylsuccinate + Sulfisoxazole Acetyl
Twintic
200 mg + 600 mg
Erythromycin Ethylsuccinate + Sulfisoxazole Acetyl
Macrolide with a sulphonamide for acute otitis media in children.
Export fast-track. DRAP export registration in about a month for products developed against export orders. Describe the formulation
- Generic composition
- Erythromycin Ethylsuccinate + Sulfisoxazole Acetyl
- Strength
- 200 mg + 600 mg
- Dosage form
- Dry Suspension
- Pack sizes
- 60 ml
- Manufacturer
- Paramount Pharmaceuticals, Islamabad
- Licence
- DML 000439 · DRAP GMP
- Release
- Batch-tested, with Certificate of Analysis
For healthcare professionals. Registration status, brand names and pack presentations vary by market. Experienced a side effect? Report it here.
Twintic
How it's made
Dry suspensions are made as a dry powder blend, filled into bottles; water is added only when the medicine is dispensed. Made in the general production section.
How all our dosage forms are made →- 01
Dispensing
Each raw material is released by QC, then weighed for the batch under a second person's check.
- 02
Dry blending
The active ingredient is blended with sweeteners, flavour and suspending agents as a dry powder.
- 03
Powder filling
Bottles are filled to a set powder weight; water is added only by the pharmacist or patient.
- 04
Capping and labelling
Bottles are sealed and labelled with the batch number and expiry date.
Batch release tests
- Fill weight
- Assay of the active ingredient
- Reconstitution and pH
- Water content
- Microbial limits
Limits for this product are on each batch's Certificate of Analysis.